Sanofi (SAN.PA) Deep Dive Video

Summary

Sanofi is rebuilding itself into an AI-powered specialty-biopharma cash compounder—yet the market prices it like Dupixent and U.S. pricing reform will break the model.

View SAN.PA stock page · Read the SAN.PA research report

Loading the video player…